Opportunity

Simpler Grants.gov #HT942526BCRPBTA4

Dept. of the Army and Defense Health Agency solicit Breast Cancer Research Breakthrough Award Level 4

Buyer

Dept. of the Army -- USAMRAA

Posted

May 04, 2026

Respond By

September 30, 2026

Identifier

HT942526BCRPBTA4

NAICS

541715

This opportunity supports high-impact breast cancer research through a major cooperative agreement: - Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Defense Health Agency, Defense Health Agency Research and Development (DHA R&D), Defense Health Agency Contracting Activity (DHACA) - Funding Opportunity: - FY26 Breast Cancer Research Program (BCRP) Breakthrough Award Level 4 - Approximate funding: $21 million for one award - Maximum period of performance: four years - Services Requested: - Clinical trial research services targeting breakthroughs in breast cancer prevention and treatment - Mandatory inclusion of at least two breast cancer consumer advocates in the research team - Projects may be led by a single Principal Investigator or two partnering Principal Investigators - Unique Requirements: - Research must address major challenges in breast cancer with high-impact potential - Clinical trials are required, including large-scale and comparative effectiveness studies - Application preparation, submission, review, post-award reporting, and milestone meetings are part of the scope - No specific OEMs or commercial products are requested; this is a research grant opportunity - Place of Performance and Review: - US Army Medical Research Acquisition Activity (USAMRAA) - National Capital Area (federal office context)

Description

The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award Level 4 supports promising research with high potential to lead to breakthroughs in breast cancer. This award requires clinical trials and the inclusion of two or more breast cancer consumer advocates on the research team. The funding mechanism allows for a single Principal Investigator or two partnering PIs. The program expects to fund approximately one award with a total cost cap of $21 million and a maximum performance period of four years.

View original listing